Godefridus J Peters Selected Research

Mesothelioma

9/2020	New Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives Inhibit FAK Phosphorylation and Potentiate the Antiproliferative Effects of Gemcitabine Through Modulation of the Human Equilibrative Nucleoside Transporter-1 in Peritoneal Mesothelioma.
1/2020	Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds.
1/2019	Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma.
1/2018	Aminopeptidase antibodies in mesothelioma: new wine deserves new sacks.
1/2018	Proton-coupled folate transporter as a biomarker of outcome to treatment for pleural mesothelioma.
12/2016	A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells, and modulated the expression of the human equilibrative transporter-1.
1/2014	Predictive role of repair enzymes in the efficacy of Cisplatin combinations in pancreatic and lung cancer.
8/2013	"One marker does not fit all": additional translational and validation studies are needed to identify faithful predictors of pemetrexed activity in mesothelioma.
12/2011	The impact of folate status on the efficacy of colorectal cancer treatment.
4/2011	Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Godefridus J Peters Research Topics

Disease

133	Neoplasms (Cancer) 04/2024 - 01/2002
43	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 02/2002
30	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 01/2009
17	Adenocarcinoma 01/2023 - 01/2009
17	Lung Neoplasms (Lung Cancer) 10/2021 - 08/2004
16	Colonic Neoplasms (Colon Cancer) 04/2024 - 08/2003
16	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 06/2007
16	Leukemia 02/2020 - 01/2002
11	Mesothelioma 09/2020 - 08/2003
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 02/2003
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 04/2004
9	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2007
9	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2003
8	Carcinogenesis 11/2023 - 05/2009
8	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 08/2004
7	Malignant Mesothelioma 05/2023 - 03/2011
7	Carcinoma (Carcinomatosis) 08/2017 - 03/2003
5	Urinary Bladder Neoplasms (Bladder Cancer) 07/2019 - 02/2002
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 11/2009
4	Gout 01/2022 - 12/2011
4	Chromosome Aberrations (Chromosome Abnormalities) 12/2016 - 11/2005
3	Hypoxia (Hypoxemia) 01/2020 - 03/2011
3	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 06/2011
3	Glioma (Gliomas) 01/2017 - 01/2017
3	Melanoma (Melanoma, Malignant) 04/2014 - 10/2007
3	Xeroderma Pigmentosum (Kaposi's Disease) 08/2013 - 03/2008

Drug/Important Bio-Agent (IBA)

49	Gemcitabine FDA Link 02/2024 - 02/2002
20	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2002
18	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 10/2005
18	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2010
18	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 03/2002
17	EnzymesIBA 11/2023 - 02/2003
16	Thymidylate SynthaseIBA 12/2022 - 01/2002
16	Fluorouracil (Carac)FDA LinkGeneric 12/2022 - 01/2002
15	ErbB Receptors (EGF Receptor)IBA 10/2021 - 04/2008
14	Folic Acid (Vitamin M)FDA LinkGeneric 03/2019 - 01/2002
13	Tyrosine Kinase InhibitorsIBA 01/2022 - 04/2008
13	Pemetrexed (MTA)FDA Link 01/2020 - 01/2002
12	Methotrexate (Mexate)FDA LinkGeneric 07/2019 - 01/2002
12	Messenger RNA (mRNA)IBA 01/2018 - 04/2002
11	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2020 - 04/2008
10	NucleosidesIBA 04/2024 - 01/2007
10	MicroRNAs (MicroRNA)IBA 10/2023 - 01/2012
10	Folic Acid AntagonistsIBA 01/2020 - 01/2002
10	PlatinumIBA 07/2019 - 06/2007
9	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024 - 09/2002
9	ProdrugsIBA 04/2024 - 05/2007
9	Sunitinib (Sutent)FDA Link 01/2022 - 12/2011
9	Phosphotransferases (Kinase)IBA 01/2022 - 10/2005
9	fluorocyclopentenylcytosineIBA 04/2020 - 12/2013
8	Lactate Dehydrogenase 5IBA 11/2023 - 03/2011
8	NucleotidesIBA 01/2023 - 04/2009
8	DeoxycytidineIBA 01/2020 - 02/2002
8	Trifluridine (Viroptic)FDA LinkGeneric 06/2014 - 03/2005
6	CrizotinibIBA 04/2021 - 01/2013
6	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 06/2010
6	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 05/2007
6	pyrimidineIBA 01/2020 - 01/2007
6	CytidineIBA 07/2019 - 12/2013
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 02/2003
6	multidrug resistance-associated protein 1IBA 01/2019 - 02/2003
6	Bortezomib (Velcade)FDA Link 01/2013 - 06/2007
6	Gefitinib (Iressa)FDA Link 01/2013 - 03/2010
5	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2002
5	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 09/2003
5	Cytidine DeaminaseIBA 10/2021 - 03/2008
5	AntimetabolitesIBA 04/2019 - 06/2007
5	trifluridine tipiracil drug combinationIBA 11/2015 - 01/2007
5	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2014 - 10/2005
5	Thymidine PhosphorylaseIBA 01/2014 - 05/2004
4	2-mercaptopurineIBA 01/2024 - 11/2009
4	AminopeptidasesIBA 01/2023 - 04/2014
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2022 - 03/2011
4	Carboplatin (JM8)FDA LinkGeneric 11/2021 - 04/2011
4	Drug CombinationsIBA 09/2020 - 01/2006
4	Thioguanine (Tioguanine)FDA Link 02/2020 - 11/2009
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2019 - 06/2007
4	Capecitabine (Xeloda)FDA Link 01/2018 - 12/2011
4	Proteasome InhibitorsIBA 01/2013 - 09/2008
4	Leucovorin (Folinic Acid)FDA Link 12/2011 - 02/2003
4	Deoxycytidine KinaseIBA 06/2011 - 04/2002
4	Irinotecan (Camptosar)FDA LinkGeneric 07/2009 - 01/2007
3	Lactic Acid (Lactate)FDA LinkGeneric 10/2023 - 11/2011
3	lissamine rhodamine B (sulforhodamine B)IBA 01/2023 - 12/2016
3	AntibodiesIBA 04/2021 - 01/2018
3	indoleIBA 09/2020 - 07/2019
3	ThiadiazolesIBA 09/2020 - 01/2020
3	CytosineIBA 04/2020 - 12/2016
3	Tyrosine (L-Tyrosine)FDA Link 02/2020 - 02/2011
3	Azathioprine (Imuran)FDA LinkGeneric 02/2020 - 11/2009
3	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 02/2020 - 11/2009
3	Uridine KinaseIBA 07/2019 - 01/2014
3	ParaffinIBA 07/2019 - 03/2010
3	MethyltransferasesIBA 04/2019 - 01/2018
3	AcridonesIBA 06/2018 - 11/2009
3	Docetaxel (Taxotere)FDA Link 08/2013 - 01/2008

Therapy/Procedure

46	Therapeutics 02/2024 - 03/2002
26	Drug Therapy (Chemotherapy) 01/2024 - 03/2002
4	Combination Drug Therapy (Combination Chemotherapy) 03/2018 - 12/2011
3	Lasers (Laser) 03/2018 - 11/2013